logo

For the Inventor, By the Inventor

Tucson, AZ, United States of America

Pavel Safar

This inventor holds 13 USPTO granted patents and 2 EPO patents. Top assignees: Aventis Pharmaceuticals Inc., Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pavel Safar. Retrieved from https://idiyas.com/inventor/pavel-safar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 38.5

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Tuscon, AZ (US) (2004)
  • Tucson, AZ (US) (1998 - 2011)
  • Oro Valley, AZ (US) (2014)

Company Filing History:

goldMedal5 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
silverMedal4 out of 1,855 
 
Sanofi-A Ventis Deutschland Gmbh
 patents
bronzeMedal2 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
4. 1 out of 1,546 
 
Sanofi
 patents
5. 1 out of 10 
 
Selectide Corporation
 patents

Years Active: 1998-2014

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 8791133 - Pyridylvinylpyrazoloquinolines as PAR1 inhibitors (2014-07-29),
2. 7994168 - Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids (2011-08-09),
3. 7750005 - Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments (2010-07-06),
4. 7652007 - Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments (2010-01-26),
5. 7393849 - Substituted sulfonamides and ureas useful for inhibiting kinase activity (2008-07-01),
6. 7390814 - Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments (2008-06-24),
7. 7323457 - Substituted sulfonamides and ureas useful for inhibiting kinase activity (2008-01-29),
8. 7223763 - Substituted sulfonamides and ureas useful for inhibiting kinase activity (2007-05-29),
9. 6777577 - Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity (2004-08-17),
10. 6759384 - Factor Xa inhibitors (2004-07-06),
11. 6500803 - Factor VIIa inhibitors (2002-12-31),
12. 6287794 - Factor Vlla inhibitors (2001-09-11),
13. 5849510 - Factor Xa inhibitors (1998-12-15),

Title: Inventor Pavel Safar - Revolutionizing Technology in Tucson

Introduction: Pavel Safar is a visionary inventor based in Tucson, Arizona, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Pavel Safar holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Pavel Safar has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Pavel Safar has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Pavel Safar's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field, with a legacy that will continue to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…